Sunshine Biopharma Inc.

NASDAQ: SBFM · Real-Time Price · USD
1.47
-0.04 (-2.65%)
At close: Aug 15, 2025, 12:27 PM

Sunshine Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.13M -4.51M -26.74M -12.44M
Depreciation & Amortization
223.53K 149.15K 25.16K 12.74K
Stock-Based Compensation
n/a n/a n/a 918K
Other Working Capital
-1.02M -94.39K 276.87K -2.88K
Other Non-Cash Items
-2.24M n/a 18.32M 10.7M
Deferred Income Tax
n/a n/a 3.63K -918K
Change in Working Capital
-5.38M -4.42M 3.15M -108.8K
Operating Cash Flow
-12.53M -8.78M -5.25M -1.83M
Capital Expenditures
-2.32M -788.1K -305K n/a
Cash Acquisitions
n/a n/a -14.35M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-2.32M -573.9K 33.38K n/a
Investing Cash Flow
-2.32M -656.15K -14.62M n/a
Debt Repayment
347.94K -125.99K -1.93M 2.9M
Common Stock Repurchased
-3.14M -541.14K -99K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.56M 3.5K 11.23M n/a
Financial Cash Flow
9.29M 3.43M 39.47M 2.9M
Net Cash Flow
-6.61M -5.53M 19.78M 1.06M
Free Cash Flow
-14.85M -9.56M -5.55M -1.83M